logo

For the Inventor, By the Inventor

Edmonton, Canada

Dragos Vizitiu

This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Gilead Calistoga LLC, Gilead Connecticut, Inc., Gilead Sciences, Inc.. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dragos Vizitiu. Retrieved from https://idiyas.com/inventor/dragos-vizitiu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

 

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal2 out of 16 
 
Gilead Calistoga LLC
 patents
silverMedal2 out of 30 
 
Gilead Connecticut, Inc.
 patents
bronzeMedal2 out of 946 
 
Gilead Sciences, Inc.
 patents
4. 1 out of 16 
 
Shire Biochem, Inc.
 patents
5. 1 out of 834,513 
Other
 patents

Years Active: 2009-2021

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 10954199 - Process methods for phosphatidylinositol 3-kinase inhibitors (2021-03-23),
2. 10414737 - Process methods for phosphatidylinositol 3-kinase inhibitors (2019-09-17),
3. 10266539 - Polymorph of Syk inhibitors (2019-04-23),
4. 10059677 - Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof (2018-08-28),
5. 10047060 - Process methods for phosphatidylinositol 3-kinase inhibitors (2018-08-14),
6. 9657023 - Polymorph of Syk inhibitors (2017-05-23),
7. 9567337 - Process methods for phosphatidylinositol 3-kinase inhibitors (2017-02-14),
8. 7501514 - Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides (2009-03-10),

Title: The Innovative Contributions of Dragos Vizitiu

Introduction

Dragos Vizitiu is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that may aid in cancer treatment. With a total of eight patents to his name, Vizitiu's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents is a process for the synthesis of quinazolinone-containing compounds, which may be useful for the treatment of cancer. This patent discloses not only the process methods for phosphatidylinositol 3-kinase inhibitors but also the compound intermediates related to these processes. His innovative approach in this area showcases his commitment to advancing cancer treatment options.

Career Highlights

Throughout his career, Dragos Vizitiu has worked with notable companies such as Gilead Connecticut, Inc. and Gilead Calistoga LLC. His experience in these organizations has allowed him to collaborate with leading experts in the pharmaceutical industry, further enhancing his expertise and contributions to the field.

Collaborations

Some of his coworkers include Stacy Bremner and Jerry B Evarts. Their collaboration has likely contributed to the successful development of his innovative patents and research.

Conclusion

Dragos Vizitiu's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving cancer treatment through scientific advancements. His contributions are a testament to the importance of research and development in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…